Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/04/08 → 31/12/12 |
Funding
- UK central government bodies/local authorities, health and hospital authorities: £714,434.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Research output
- 6 Article
-
A novel mechanism of action of HER2 targeted immunotherapy is explained by inhibition of NRF2 function in ovarian cancer cells
Khalil, H. S., Langdon, S., Goltsov, A., Soininen, T., Harrison, D., Bown, J. & Deeni, Y., 4 Oct 2016, In: Oncotarget.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models
Koussounadis, A., Langdon, S., Um, I., Kay, C., Francis, K., Harrison, D. & Smith, V. A., 10 Mar 2016, In: BMC Cancer. 16, 1, p. 205Research output: Contribution to journal › Article › peer-review
Open AccessFile -
The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancer
Huang, R., Langdon, S., Tse, M., Mullen, P., Um, I. H., Faratian, D. & Harrison, D., 14 Dec 2015, In: Oncotarget.Research output: Contribution to journal › Article › peer-review
Open AccessFile